• Anand Anandkumar, Co-founder and CEO Bugworks Research Inc (India)
  • Kamini Walia, Program Officer, ICMR-AMR Initiative (India) 

Moderator: François Franceschi, GARDP 

In this webinar, Anand Anandkumar and Kamini Walia discussed:

  • Why is India one of the hotbeds of the AMR problem? Latest statistics of growing drug resistance etc.
  • Initiatives of the Indian Government to curb the AMR problem
  • Antimicrobial R&D landscape in India – a vibrant ecosystem supporting innovation in AMR diagnosis, prevention and therapeutics
  • Fledgling antimicrobial clinical trial networks – could trials out of India play a significant role in gaining global regulatory approvals?
  • Changing regulatory environment to enable accelerated approvals for antimicrobial products

This live webinar including interactive Q&A session was broadcast on 9 July 2020.

If you have questions or comments, please let us know: revive@gardp.org.